Kiromic Biopharma Inc. WKN: A3D7BN ISIN: US4976342042 Kürzel: KRBP Forum: Aktien User: Solix

What's Going On With Kiromic BioPharma Stock Wednesday https://www.benzinga.com/general/biotech/23/05/32190317/whats-going-on-with-kiromic-biopharma-stock-wednesday Kiromic BioPharma Inc (NASDAQ:KRBP) shares are gaining Wednesday morning. However there is no specific news today. During the session, the share price reached $9.22. Monday morning, the FDA authorized the company's Investigational New Drug (IND) application to initiate a Phase 1 trial to evaluate Deltacel (KB-GDT-01) for patients with non-small cell lung cancer (NSCLC). The company expects to start the trial in Q2 of 2023. Deltacel is the company's allogeneic, non- engineered, off-the-shelf Gamma Delta T-cell therapy. The company submitted the IND application in early April. Kiromic BioPharma stock is gaining on heavy volume, with a session volume of 3.6 million shares traded, compared to the trailing 100- day volume of 164.038K shares.